Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
ICC negotiations down to the wire ahead of pivotal Senate vote

ICC negotiations down to the wire ahead of pivotal Senate vote

A bipartisan deal on legislation to sanction the International Criminal Court over its targeting of Israeli officials remains elusive ahead of a 2:15 p.m. Senate vote on advancing the bill.

All 53 Republicans are expected to back the measure, and GOP leaders believe there are enough Democrats who would vote to advance it to overcome a filibuster. But Democratic leaders want to avoid splitting the party on such a contentious issue and are aiming to clinch an agreement before the first procedural vote this afternoon. If there’s no deal and enough Democrats side with their leadership, the bill won’t move forward in its current form.

As we scooped, Democrats believe the GOP-drafted measure is too broad and would impose sanctions on U.S. tech companies like Google, Microsoft and Meta. Representatives from the three companies got on a conference call with the negotiators last night, we’re told.

Democrats on the Senate Foreign Relations Committee gathered after votes Monday to get an update from the panel’s top Democrat, Sen. Jeanne Shaheen of New Hampshire, who told reporters she was still negotiating with Intelligence Committee Chair Tom Cotton (R-Ark.), the bill’s chief sponsor.

A senior GOP aide said the negotiations are intended to “clarify” the bill’s language, but said Senate Republicans “are united and won’t accept anything that weakens the bill.” The aide also disputed the notion that U.S. companies could be targeted and insisted that the companies believe they can “firewall” themselves from sanctions.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.